Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 74Colonic Neoplasms 31Rectal Neoplasms 29Neoplasm Metastasis 15Stomach Neoplasms 12Pancreatic Neoplasms 11Small Cell Lung Carcinoma 7Esophageal Squamous Cell Carcinoma 7Neoplasms 6Esophageal Neoplasms 6Rhabdomyosarcoma 4Intestinal Neoplasms 4Gastrointestinal Neoplasms 4Digestive System Neoplasms 4Uterine Cervical Neoplasms 3Sarcoma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Cholangiocarcinoma 3Biliary Tract Neoplasms 3Rectal Diseases 2Neuroblastoma 2Neoplasms by Histologic Type 2Intestinal Diseases 2Hepatoblastoma 2Gastrointestinal Diseases 2Ganglioneuroblastoma 2Digestive System Diseases 2Colorectal Cancer Metastatic 2Colorectal Adenocarcinoma 2Colonic Diseases 2

Interventions

tislelizumab 1motexafin gadolinium 1Tamoxifen 1Talaporfin 1Radiotherapy 1Oxaliplatin 1Mitomycin 1Lomustine 1Irinotecan 1Gemcitabine 1Folfox protocol 1Fluorouracil 1Ethiodized Oil 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Recurrence, Local × Irinotecan × Clear all
NCT02087475 2019-06-05

Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Unknown
360 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasm Recurrence, Local, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡